Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Frontotemporal dementia: latest evidence and clinical implications.

Young JJ, Lavakumar M, Tampi D, Balachandran S, Tampi RR.

Ther Adv Psychopharmacol. 2018 Jan;8(1):33-48. doi: 10.1177/2045125317739818. Epub 2017 Nov 10. Review.

2.

The Evolution of TP53 Mutations: From Loss-of-Function to Separation-of-Function Mutants.

Miller M, Shirole N, Tian R, Pal D, Sordella R.

J Cancer Biol Res. 2016;4(4). pii: 1091. Epub 2016 Dec 23.

3.

Novel GRN Mutations in Patients with Corticobasal Syndrome.

Taghdiri F, Sato C, Ghani M, Moreno D, Rogaeva E, Tartaglia MC.

Sci Rep. 2016 Mar 10;6:22913. doi: 10.1038/srep22913.

4.

Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice.

Maeda S, Djukic B, Taneja P, Yu GQ, Lo I, Davis A, Craft R, Guo W, Wang X, Kim D, Ponnusamy R, Gill TM, Masliah E, Mucke L.

EMBO Rep. 2016 Apr;17(4):530-51. doi: 10.15252/embr.201541438. Epub 2016 Mar 1.

5.

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort.

Van Mossevelde S, van der Zee J, Gijselinck I, Engelborghs S, Sieben A, Van Langenhove T, De Bleecker J, Baets J, Vandenbulcke M, Van Laere K, Ceyssens S, Van den Broeck M, Peeters K, Mattheijssens M, Cras P, Vandenberghe R, De Jonghe P, Martin JJ, De Deyn PP, Cruts M, Van Broeckhoven C; Belgian Neurology consortium.

Brain. 2016 Feb;139(Pt 2):452-67. doi: 10.1093/brain/awv358. Epub 2015 Dec 15.

6.

Frontotemporal Dementia.

Kelley RE, El-Khoury R.

Neurol Clin. 2016 Feb;34(1):171-81. doi: 10.1016/j.ncl.2015.08.007. Review.

7.

Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau protein.

Grimm A, Biliouris EE, Lang UE, Götz J, Mensah-Nyagan AG, Eckert A.

Cell Mol Life Sci. 2016 Jan;73(1):201-15. doi: 10.1007/s00018-015-1988-x. Epub 2015 Jul 22.

8.

Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging.

Ghetti B, Oblak AL, Boeve BF, Johnson KA, Dickerson BC, Goedert M.

Neuropathol Appl Neurobiol. 2015 Feb;41(1):24-46. doi: 10.1111/nan.12213. Review. Erratum in: Neuropathol Appl Neurobiol. 2015 Jun;41(4):571. Neuropathol Appl Neurobiol. 2015 Jun;41(4):571.

9.

Parkinsonian syndrome in familial frontotemporal dementia.

Siuda J, Fujioka S, Wszolek ZK.

Parkinsonism Relat Disord. 2014 Sep;20(9):957-64. doi: 10.1016/j.parkreldis.2014.06.004. Epub 2014 Jun 13. Review.

10.

Subcortical and Deep Cortical Atrophy in Frontotemporal Dementia due to Granulin Mutations.

Premi E, Garibotto V, Gazzina S, Formenti A, Archetti S, Gasparotti R, Padovani A, Borroni B.

Dement Geriatr Cogn Dis Extra. 2014 Apr 23;4(1):95-102. doi: 10.1159/000355428. eCollection 2014 Jan.

11.

New perspective on parkinsonism in frontotemporal lobar degeneration.

Park HK, Chung SJ.

J Mov Disord. 2013 May;6(1):1-8. doi: 10.14802/jmd.13001. Epub 2013 May 30. Review.

12.

Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition.

Selenica ML, Benner L, Housley SB, Manchec B, Lee DC, Nash KR, Kalin J, Bergman JA, Kozikowski A, Gordon MN, Morgan D.

Alzheimers Res Ther. 2014 Feb 27;6(1):12. doi: 10.1186/alzrt241. eCollection 2014.

13.

Magnetic resonance spectroscopy in common dementias.

Kantarci K.

Neuroimaging Clin N Am. 2013 Aug;23(3):393-406. doi: 10.1016/j.nic.2012.10.004. Epub 2013 Feb 27. Review.

14.

Agraphia in patients with frontotemporal dementia and parkinsonism linked to chromosome 17 with P301L MAPT mutation: dysexecutive, aphasic, apraxic or spatial phenomenon?

Sitek EJ, Narozanska E, Barczak A, Jasinska-Myga B, Harciarek M, Chodakowska-Zebrowska M, Kubiak M, Wieczorek D, Konieczna S, Rademakers R, Baker M, Berdynski M, Brockhuis B, Barcikowska M, Zekanowski C, Heilman KM, Wszolek ZK, Slawek J.

Neurocase. 2014;20(1):69-86. doi: 10.1080/13554794.2012.732087. Epub 2012 Nov 5.

15.

Evolution of neurodegeneration.

Cookson MR.

Curr Biol. 2012 Sep 11;22(17):R753-61. doi: 10.1016/j.cub.2012.07.008. Review.

16.

Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia.

Galimberti D, Dell'Osso B, Fenoglio C, Villa C, Cortini F, Serpente M, Kittel-Schneider S, Weigl J, Neuner M, Volkert J, Leonhard C, Olmes DG, Kopf J, Cantoni C, Ridolfi E, Palazzo C, Ghezzi L, Bresolin N, Altamura AC, Scarpini E, Reif A.

PLoS One. 2012;7(4):e32164. doi: 10.1371/journal.pone.0032164. Epub 2012 Apr 10.

17.

Update on the Diagnosis and Management of Sleep Disturbances in Dementia.

Boeve BF.

Sleep Med Clin. 2008 Sep;3(3):347-360. No abstract available.

18.

Parkinsonism and frontotemporal dementia: the clinical overlap.

Espay AJ, Litvan I.

J Mol Neurosci. 2011 Nov;45(3):343-9. doi: 10.1007/s12031-011-9632-1. Epub 2011 Sep 3.

19.

PSF suppresses tau exon 10 inclusion by interacting with a stem-loop structure downstream of exon 10.

Ray P, Kar A, Fushimi K, Havlioglu N, Chen X, Wu JY.

J Mol Neurosci. 2011 Nov;45(3):453-66. doi: 10.1007/s12031-011-9634-z. Epub 2011 Sep 1.

20.

Altered functional connectivity in asymptomatic MAPT subjects: a comparison to bvFTD.

Whitwell JL, Josephs KA, Avula R, Tosakulwong N, Weigand SD, Senjem ML, Vemuri P, Jones DT, Gunter JL, Baker M, Wszolek ZK, Knopman DS, Rademakers R, Petersen RC, Boeve BF, Jack CR Jr.

Neurology. 2011 Aug 30;77(9):866-74. doi: 10.1212/WNL.0b013e31822c61f2. Epub 2011 Aug 17.

Supplemental Content

Support Center